Viewing StudyNCT00290771



Ignite Creation Date: 2024-05-05 @ 4:41 PM
Last Modification Date: 2024-10-26 @ 9:22 AM
Study NCT ID: NCT00290771
Status: TERMINATED
Last Update Posted: 2011-05-16
First Post: 2006-02-10

Brief Title: Efficacy and Safety of Imatinib Mesylate Plus Hydroxyurea HU in Patients With Recurrent Glioblastoma Multiforme GBM
Sponsor:
Organization: Novartis